Aperio Clinical Outcomes

Executive Summary

Aperio Clinical Outcomes provides specialized data management and advanced analytics services for clinical trials, with a focus on oncology and rare diseases. By building fit-for-purpose databases and ensuring data integrity and patient safety, the company addresses the growing complexity of clinical trial data. Aperio positions itself as a strategic partner for sponsors, offering tailored solutions to navigate increasing data volumes and regulatory demands. Its expertise in complex trials and commitment to quality differentiate it in the competitive digital health analytics market. Founded in 2018 and based in San Francisco, Aperio operates in a niche but expanding segment of the clinical trial ecosystem. The shift toward decentralized trials and the need for real-time data monitoring are driving demand for specialized analytics providers. While the company has not disclosed funding or revenue, its focus on high-value therapeutic areas and its service-oriented model suggest steady growth potential. Key risks include reliance on client acquisition and competition from larger CROs with embedded analytics capabilities.

Upcoming Catalysts (preview)

• Q3 2026New Partnership with Top-20 Pharma for Rare Disease Trial60% success
• Q4 2026Launch of AI-Powered Predictive Safety Analytics Module50% success
• Q2 2026Expansion into Central Nervous System (CNS) Trial Analytics70% success